MyBiotics

MyBiotics is a life sciences company dedicated to developing probiotic and live bacteria-based products to improve health and quality of life. MyCrobeTM and SuperDonorTM place the company at the forefront of the microbiology field, with both technologies addressing three key factors in the probiotics development market: delivery, targeting, and colonization. MyCrobeTM and SuperDonorTM provide single or multi-bacterial combinations for targeted therapies, full microbiome restoration, and the first practical screening method as an alternative to FMT (fecal microbiota transplantation). MyBiotics focuses on restoring bacterial populations to a healthy balance through the use of live bacteria, which will colonize and compete within existing pathogenic populations.